These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 11583893

  • 1. Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension: response to iloprost inhalation.
    Wiedemann R, Ghofrani HA, Weissmann N, Schermuly R, Quanz K, Grimminger F, Seeger W, Olschewski H.
    J Am Coll Cardiol; 2001 Oct; 38(4):1130-6. PubMed ID: 11583893
    [Abstract] [Full Text] [Related]

  • 2. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W.
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [Abstract] [Full Text] [Related]

  • 3. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension.
    Wensel R, Opitz CF, Ewert R, Bruch L, Kleber FX.
    Circulation; 2000 May 23; 101(20):2388-92. PubMed ID: 10821815
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise.
    Blumberg FC, Riegger GA, Pfeifer M.
    Chest; 2002 May 23; 121(5):1566-71. PubMed ID: 12006445
    [Abstract] [Full Text] [Related]

  • 5. Oxygen-mediated pulmonary vasodilation and plasma levels of endothelin-1, atrial natriuretic peptide and cyclic GMP in patients with left-to-right shunt and pulmonary hypertension.
    Gorenflo M, Bettendorf M, Ulmer HE, Brockmeier K.
    Z Kardiol; 2000 Feb 23; 89(2):100-8. PubMed ID: 10768278
    [Abstract] [Full Text] [Related]

  • 6. Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders.
    Ghofrani HA, Wiedemann R, Rose F, Weissmann N, Schermuly RT, Quanz K, Grimminger F, Seeger W, Olschewski H.
    Eur Respir J; 2002 Apr 23; 19(4):664-71. PubMed ID: 11998996
    [Abstract] [Full Text] [Related]

  • 7. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF, Wensel R, Bettmann M, Schaffarczyk R, Linscheid M, Hetzer R, Ewert R.
    Eur Heart J; 2003 Feb 23; 24(4):356-65. PubMed ID: 12581683
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
    Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J.
    Chest; 2004 Feb 23; 125(2):580-6. PubMed ID: 14769741
    [Abstract] [Full Text] [Related]

  • 9. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A.
    Pol Arch Med Wewn; 2001 Jun 23; 105(6):475-82. PubMed ID: 11865578
    [Abstract] [Full Text] [Related]

  • 10. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L, Yang YH, Cui N, Xie WM, Zhai ZG, Ma ZH, Wang C.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2103-5. PubMed ID: 20058612
    [Abstract] [Full Text] [Related]

  • 11. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
    Theodoraki K, Rellia P, Thanopoulos A, Tsourelis L, Zarkalis D, Sfyrakis P, Antoniou T.
    Can J Anaesth; 2002 Nov 11; 49(9):963-7. PubMed ID: 12419726
    [Abstract] [Full Text] [Related]

  • 12. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX, Yang YH, Geng J, Zhai ZG, Gong JN, Li JF, Tang X, Wang C.
    Chin Med J (Engl); 2017 Feb 20; 130(4):382-391. PubMed ID: 28218209
    [Abstract] [Full Text] [Related]

  • 13. Recovery from circulatory shock in severe primary pulmonary hypertension (PPH) with aerosolization of iloprost.
    Olschewski H, Ghofrani HA, Walmrath D, Temmesfeld-Wollbrück B, Grimminger F, Seeger W.
    Intensive Care Med; 1998 Jun 20; 24(6):631-4. PubMed ID: 9681789
    [Abstract] [Full Text] [Related]

  • 14. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ.
    Respiration; 2008 Jun 20; 76(2):154-9. PubMed ID: 17804899
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.
    Ann Intern Med; 1996 May 01; 124(9):820-4. PubMed ID: 8610951
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
    Tian Z, Chen TB, Fang Q, Zeng XF, Liu YT, Li MT, Jiang XC, Gao P, Cheng KA, Wang Q.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2099-102. PubMed ID: 20058611
    [Abstract] [Full Text] [Related]

  • 17. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.
    Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M, Nakanishi N, Takamiya M, Kunieda T, Matsuo H, Kangawa K.
    J Am Coll Cardiol; 1998 Jan 11; 31(1):202-8. PubMed ID: 9426041
    [Abstract] [Full Text] [Related]

  • 18. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
    Rex S, Schaelte G, Metzelder S, Flier S, de Waal EE, Autschbach R, Rossaint R, Buhre W.
    Acta Anaesthesiol Scand; 2008 Jan 11; 52(1):65-72. PubMed ID: 17976224
    [Abstract] [Full Text] [Related]

  • 19. [Effects of inhaled aerosolized iloprost in adult patients with pulmonary arterial hypertension on right heart functions].
    Guo XX, Tian Z, Liu YT, Wang Q, Li MT, Zeng XF, Zhu WL, Fang Q.
    Zhonghua Yi Xue Za Zhi; 2011 Nov 01; 91(40):2832-6. PubMed ID: 22333544
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E.
    Eur J Cardiothorac Surg; 2002 Nov 01; 22(5):746-52. PubMed ID: 12414041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.